REFERENCES
  1. Shiohara T. Fixed drug eruption. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. Accessed on 04/26/22.
  2. Byrd RC, Mournighan KJ, Baca-Atlas M, Helton MR, Sun NZ, Siegel MB. Generalized bullous fixed-drug eruption secondary to the influenza vaccine. JAAD Case Rep. 2018 Oct 12;4(9):953-955. doi: 10.1016/j.jdcr.2018.07.013. PMID: 30364778; PMCID: PMC6197945.
  3. Pyl J, Aerts O, Siozopoulou V, Lambert J, Dendooven E, Poschet K, Dandelooy J. Bullous fixed drug eruption following Human Papilloma Virus vaccination. J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e697-e698. doi: 10.1111/jdv.16377. Epub 2020 Jul 20. PMID: 32181534.
  4. Wantavornprasert K, Noppakun N, Klaewsongkram J, Rerknimitr P. Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination. Clin Exp Dermatol. 2022 Feb;47(2):428-432. doi: 10.1111/ced.14926. Epub 2021 Oct 10. PMID: 34482558; PMCID: PMC8652793.
  5. Kong J, Cuevas-Castillo F, Nassar M, Lei CM, Idrees Z, Fix WC, Halverstam C, Mir A, Elbendary A, Mathew A. Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report. J Infect Public Health. 2021 Oct;14(10):1392-1394. doi: 10.1016/j.jiph.2021.06.021. Epub 2021 Jul 8. PMID: 34294590; PMCID: PMC8264280.
  6. Mintoff D, Pisani D, Betts A, Scerri L. SARS-CoV-2 mRNA vaccine-associated fixed drug eruption. J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e560-e563. doi: 10.1111/jdv.17390. Epub 2021 Jun 11. PMID: 34036651.
  7. Ben Salem C, Khelif A, Sahnoun D, Ghariani N, Sriha B, Denguezli M. Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19). J Eur Acad Dermatol Venereol. 2022 Mar 11. doi: 10.1111/jdv.18059. Epub ahead of print. PMID: 35274363.
  8. Lellig E, Mouton-Faivre C, Abs D, Bursztejn AC. Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: a case report. J Allergy Clin Immunol Pract. 2022 Apr 21:S2213-2198(22)00350-6. doi: 10.1016/j.jaip.2022.03.033. Epub ahead of print. PMID: 35470099
  9. Seirafianpour F, Pourriyahi H, Gholizadeh Mesgarha M, Pour Mohammad A, Shaka Z, Goodarzi A. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders. Dermatol Ther. 2022 Mar 22:e15461. doi: 10.1111/dth.15461. Epub ahead of print. PMID: 35316551.